NRXS News
Archived Headlines
- US IPO Weekly Recap: Calendar is quieter than expected as more small IPOs join the pipeline 02/17/23
- Medical device maker NeurAxis sets proposed price at $8 and adds warrants ahead of $15 million IPO 02/13/23
- US IPO Week Ahead: IPO market heats up with solar trackers, lidar tech, and hypertension drugs 02/03/23
- US IPO Week Ahead: IPO market kicks off February with a sizable biotech and more small deals 01/27/23
- Medical device maker NeurAxis sets terms for $15 million IPO 01/26/23
See more
US IPO Weekly Recap: IPO market sees fitness, liquor marketing, and medical devices
Three small issuers began trading this past week, two of which were eligible for inclusion in our IPO stats. Australia-based Fitell (FTEL) priced at the low end to raise $15 million at a $56 million market cap. The fitness retailer sells...read more
Medical device maker NeurAxis prices IPO at $6
NeurAxis, which makes a non-surgical neuromodulation device for children with IBS-related pain, raised $7 million by offering 1.1 million shares at $6, as expected. The company offered 68 thousand fewer shares than anticipated. Concurrently, selling...read more
US IPO Week Ahead: SharkNinja is the big fish in a week with small deals
Four or more companies could list in the week ahead. While it is not an IPO, the week’s largest and most notable new listing comes from US-based appliance maker SharkNinja (SN). We could still see a notable deal or two launch, but time...read more
Medical device maker NeurAxis revises terms, changes listing exchange ahead of $8 million IPO
NeurAxis, which makes a non-surgical neuromodulation device for children with IBS-related pain, revised the terms for its upcoming IPO on Thursday. In its latest filing, the company also changed the proposed listing exchange from the Nasdaq to the NYSE American....read more